CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 5 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,950 | +22.4% | 402 | 0.0% | 0.00% | – |
| Q2 2023 | $8,944 | +2.8% | 402 | 0.0% | 0.00% | – |
| Q1 2023 | $8,703 | +6.7% | 402 | 0.0% | 0.00% | – |
| Q4 2022 | $8,160 | -18.4% | 402 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | 0.0% | 402 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | +11.1% | 402 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | +12.5% | 402 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | 0.0% | 402 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | -11.1% | 402 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | -10.0% | 402 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | -9.1% | 402 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | +57.1% | 402 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | 0.0% | 402 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 402 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | 0.0% | 402 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | -16.7% | 402 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | – | 402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |